Ayurvedic Manufacturing Buyer FAQ

Private label uses an established formula under your brand; custom work builds or changes a specification for your brief. Ask which changes trigger development, how the supplier controls materials and what testing supports the finished product. Neither route removes ingredient eligibility, claims review or release responsibilities.

Start with the botanical Latin name, plant part and material form. Ask the supplier and laboratory which authenticated references and suitable methods support identity for that matrix. A commercial herb name or marker percentage cannot establish the full identity decision, particularly when processing changes the material.

Different parts of the same species can have different compositions and purchasing requirements. State root, leaf, rhizome, fruit or the agreed combination in the specification and label records. Review a proposed part change as a substitution that may affect claims, analytical evidence and the finished formula.

An extract ratio describes a manufacturing relationship under its stated definition. Ask whether it concerns native extract or the supplied material with carriers, and request relevant solvent and process information. A ratio alone does not establish equivalent dose, marker content, identity or clinical performance.

Standardization sets a compositional target for named markers under a defined method. It does not prove clinical efficacy, species identity or safety. Ask which compounds the specification covers and have a qualified reviewer assess any performance claim against evidence for the actual product and intended use.

An assay may report a result on a dry basis or for material as supplied. Moisture, carriers and calculation choices can affect comparison. Ask the laboratory to name the compounds, method and basis, then align those details across supplier quotes and the approved ingredient specification.

Not without review. A raw powder and extract can differ in composition, serving requirements, physical behavior and evidence needs. Ask technical and regulatory reviewers to assess the change, then update the specification, label, claims and release plan where needed. Price or weight alone cannot establish interchangeability.

A qualified laboratory should select methods that fit the extract and the purchasing identity question. Processing can remove plant structures or recoverable DNA. Ask about authenticated references, chromatographic fingerprints and complementary evidence where appropriate, including limitations. Do not prescribe DNA testing or one marker assay for every extract.

Ask for a risk assessment based on the botanical, source, process, intended serving and market. Metals, microbiology, pesticides, residual solvents, mycotoxins or adulteration may warrant work. Qualified reviewers should set the selected scope and criteria; no universal panel or copied limit resolves every product risk.

It should identify the finished batch and the agreed release evidence, with results, methods, units and reporting limits where applicable. Ask how the batch connects to incoming ingredient lots and the finished specification. An ingredient COA remains supporting evidence, not a description of every manufacturing and packaging step.

Check the current certificate holder, certifying body, activities and eligible product or line scope. Ask for records connecting your SKU and handling arrangements to that coverage. Organic status does not establish absence of contaminants, and a supplier logo does not prove that every formula it makes qualifies.

Review the full formulation, capsule or delivery materials, carriers and relevant processing inputs with the supplier. Ask what records support the intended claim and how substitutions are controlled. A botanical headline ingredient does not establish that every other ingredient or manufacturing input meets the brand’s vegan requirements.

Ask what stability evidence supports the actual formula in the selected pack under stated storage conditions. Have qualified staff explain relevant results and remaining work. Confirm coding and buyer delivery requirements. Do not copy a duration from another product or assume a packaging change leaves the evidence unchanged.

State pack material, closure, fill count or weight, labeling, coding and case requirements. Ask the technical team about compatibility, seals and storage protection for the chosen format. Confirm who purchases components and owns unused stock. Packaging affects product evidence and distribution, not just the unit price or appearance.

Use a qualified regulatory reviewer for the intended market and exact formula. Include product names, labels, listings, images, buyer sheets and creator content. Traditional use alone does not substantiate a modern disease claim. Keep approved wording and evidence together so marketing revisions trigger review rather than bypass it.

No. The account operator must check current Seller Central instructions, ingredient eligibility and required verification for the actual product. A manufacturer can supply documents without guaranteeing acceptance. Resolve account-specific gaps before committing inventory to that channel, and keep platform approval separate from factory release.

Ask the buyer for its current onboarding requirements. Prepare a controlled specification, label, relevant scoped certificates, batch evidence, shelf-life support, identifiers, pack and case data, and quality contacts. Buyer requests vary and do not replace your own ingredient eligibility, claims review or supplier-qualification decisions.

Require notice and approval before changes to species, plant part, extract source, solvent, carrier or other agreed attributes. Ask the manufacturer to assess label, claims, analytical and stability consequences. Record the approved decision and affected versions; a similar common name or lower price does not authorize replacement.